Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has shared an update.
Proteomics International Laboratories Ltd announced the issuance of new unquoted equity securities, specifically options expiring in 2028 and 2029. This move may impact the company’s financial strategy and provide additional resources for its ongoing projects, potentially strengthening its position in the biotechnology sector.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd operates in the biotechnology industry, focusing on the development of diagnostic tests and analytical services. The company is known for its work in proteomics, which involves studying proteins to develop innovative healthcare solutions.
Average Trading Volume: 284,973
Technical Sentiment Signal: Sell
Current Market Cap: A$54.83M
See more insights into PIQ stock on TipRanks’ Stock Analysis page.